Search results for "Respiratory tract infection"

showing 9 items of 99 documents

The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell trans…

2019

The effect of timing of community acquired respiratory virus (CARV) infection after allogeneic hematopoietic stem cell transplant (allo-HCT) is an as yet unsettled issue. We evaluate this issue by including all consecutive allo-HCT recipients with molecularly-documented CARV infection during the first year after transplant. The study cohort was drawn from a prospective longitudinal survey of CARV in allo-HCT recipient having respiratory symptoms conducted from December 2013 to December 2018 at two Spanish transplant centers. Respiratory viruses in upper and/or lower respiratory specimens were tested using multiplex PCR panel assays. The study cohort comprised 233 allo-HCT recipients with 37…

medicine.medical_specialtyMultivariate analysisEpidemiologymedicine.medical_treatmentHematopoietic stem cell transplantationArticle03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicineHumansProspective StudiesRespiratory systemRespiratory Tract InfectionsTransplantationbusiness.industryHematopoietic Stem Cell TransplantationHematologyOdds ratioConfidence intervalStem-cell researchVirus Diseases030220 oncology & carcinogenesisCohortVirusesRespiratory virusbusiness030215 immunologyBone marrow transplantation
researchProduct

P343 Procalcitonin role in the management of lower respiratory tract infections in preschool children

2017

Introduction One of the major advantage of procalcitonin compared to other parameters is its highly and early increase in response to bacterial infection. The increased procalcitonin levels can be observed 3 to 6 hours after infectious challenge. It is a parameter that made a significant contribution to the clinical diagnosis, severity of infection and in the same time procalcitonin kinetics cand be used to assess the effectiveness of treatment. Methods A single- centre observational study consecutively enrolled 70 preschool children with lower respiratory tract infections who were hospitalised in Paediatric Clinic Hospital of Sibiu between January 2013 and January 2017. Procalcitonin, were…

medicine.medical_specialtyPaediatric clinicRespiratory tract infectionsmedicine.drug_classbusiness.industryAntibioticsBronchopneumoniamedicine.diseaseProcalcitoninClinical diagnosisInternal medicinemedicineObservational studybusinessIntensive care medicineHospital stayPosters
researchProduct

Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.

2021

RATIONALE: Pityriasis rosea Gibert is an erythematous-papulosquamous dermatosis that frequently occurs in young adults. The etiopathogenesis of PR is still unknown, but is frequently associated with episodes of upper respiratory tract infections. It is likely that a new viral trigger of pityriasis rosea is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PATIENT CONCERNS: We present the case of a female patient in whom the diagnosis of pityriasis rosea led to the investigation and diagnosis of the SARS-CoV-2 infection. The patient presented to the Department of Dermatology for a 3 week duration of an extremely pruritic erythematous-squamous lesion, initially on the trunk …

medicine.medical_specialtyPityriasis RoseaContext (language use)Lesion03 medical and health sciencescoronavirus disease 20190302 clinical medicineAdrenal Cortex HormonesmedicineHumans030212 general & internal medicineClinical Case ReportRespiratory tract infectionsbusiness.industrySARS-CoV-24900COVID-19pityriasis rosea GibertGeneral MedicineMiddle Agedmedicine.diseaseDermatologyRashTopical medicationmedicine.anatomical_structure030220 oncology & carcinogenesisPityriasis roseaEtiologyFemalemedicine.symptombusinessRespiratory tractResearch Articlesevere acute respiratory syndrome coronavirus 2Medicine
researchProduct

Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019

2020

<b><i>Introduction:</i></b> As red blood cell distribution width (RDW) significantly predicts clinical outcomes in patients with respiratory tract infections and in those with critical illnesses, we performed a critical analysis of the literature to explore the potential prognostic role of this laboratory parameter in coronavirus disease 2019 (COVID-19). <b><i>Methods:</i></b> An electronic search was conducted in Medline, Scopus and Web of Science, using the keywords “coronavirus disease 2019” OR “COVID-19” AND “red blood cell distribution width” OR “RDW” in all fields, up to the present time, with no language restriction. Studies reporting t…

medicine.medical_specialtyRespiratory tract infectionsCoronavirus disease 2019 (COVID-19)business.industryCOVID-19 Coronavirus Red blood cell distribution widthMEDLINECOVID-19Red blood cell distribution widthHematologyGeneral Medicinemedicine.disease_causeCoronavirusRed blood cellmedicine.anatomical_structureRed blood cell distribution widthInternal medicinemedicineDistribution (pharmacology)In patientSystematic ReviewbusinessCoronavirus
researchProduct

Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation o…

2013

Abstract Biomarker-guided initiation of antibiotic therapy has been studied in four conditions: acute pancreatitis, lower respiratory tract infection (LRTI), meningitis, and sepsis in the ICU. In pancreatitis with suspected infected necrosis, initiating antibiotics best relies on fine-needle aspiration and demonstration of infected material. We suggest that PCT be measured to help predict infection; however, available data are insufficient to decide on initiating antibiotics based on PCT levels. In adult patients suspected of community-acquired LRTI, we suggest withholding antibiotic therapy when the serum PCT level is low (<0.25 ng/mL); in patients having nosocomial LRTI, data are insuf…

medicine.medical_specialty[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicine.drug_class[SHS.INFO]Humanities and Social Sciences/Library and information sciencesAntibioticsReviewpneumonia;meningitis;pancreatitis;infection;sepsis;emergency medicine;biomarkers;procalcitonin;C-reactive proteinCritical Care and Intensive Care Medicine[SHS.INFO] Humanities and Social Sciences/Library and information sciencesProcalcitoninC-reactive proteinSepsis03 medical and health sciences0302 clinical medicineLower respiratory tract infectionSepsismedicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][ SHS.INFO ] Humanities and Social Sciences/Library and information sciencesMeningitis030212 general & internal medicineIntensive care medicine: Infectionddc:6160303 health sciences030306 microbiologybusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Pneumoniamedicine.disease3. Good healthDiscontinuationPneumoniaPancreatitisPancreatitisEmergency medicineInfectionbusinessMeningitisProcalcitoninBiomarkersAnnals of Intensive Care
researchProduct

Post-infectious myocardial Infarction: Does percutaneous coronary intervention improve outcomes? A propensity-score matched analysis

2020

Acute infection is a frequent trigger of myocardial infarction (MI). However, whether percutaneous coronary intervention (PCI) improves post-infectious MI prognosis is a major but unsolved issue. In this prospective multicenter study from coronary care units, we performed propensity score-matched analysis to compare outcomes in patients with and without PCI for post-infectious MI with angiography-proven significant coronary stenosis (&gt

medicine.medical_specialtyrespiratory tract infectionmedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyArticletype 2 myocardial infarctionCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicinemedicinepneumonia030212 general & internal medicinecardiovascular diseasesMyocardial infarctionProspective cohort studycoronary care unitbusiness.industrylcsh:Rpercutaneous coronary interventionPercutaneous coronary interventionGeneral Medicinemedicine.diseasemortalityStenosismyocardial infarctionsurgical procedures operativeConventional PCIPropensity score matchingCoronary care unitoutcomeCardiologyObservational studyCardiology and Cardiovascular Medicinebusinessacute infectionArchives of Cardiovascular Diseases Supplements
researchProduct

RSV disease in infants and young children: Can we see a brighter future?

2022

Respiratory syncytial virus (RSV) is a highly contagious seasonal virus and the leading cause of Lower Respiratory Tract Infections (LRTI), including pneumonia and bronchiolitis in children. RSV-related LRTI cause approximately 3 million hospitalizations and 120,000 deaths annually among children <5 years of age. The majority of the burden of RSV occurs in previously healthy infants. Only a monoclonal antibody (mAb) has been approved against RSV infections in a restricted group, leaving an urgent unmet need for a large number of children potentially benefiting from preventive measures. Approaches under development include maternal vaccines to protect newborns, extended half-life monoclon…

respiratory syncytial virusImmunologyRSV vaccinesRespiratory Syncytial Virus InfectionsCommunicable DiseasesRSV preventionRSV all infantsImmunology and AllergyHumansChildmonoclonal antibodieRespiratory Tract InfectionsPharmacologyRSV all infantInfant NewbornRSVInfantAntibodies MonoclonalRSV paediatric burdenHospitalizationLRTIRSV epidemiologyChild PreschoolRespiratory Syncytial Virus HumanBronchiolitismonoclonal antibodiesLRTI; RSV; RSV all infants; RSV epidemiology; RSV paediatric burden; RSV prevention; RSV vaccines; monoclonal antibodies; respiratory syncytial virusRSV prevention: RSV vaccines.Human vaccinesimmunotherapeutics
researchProduct

Rapid and sensitive detection of metapneumovirus in clinical specimens by indirect fluorescence assay using a monoclonal antibody.

2008

Human metapneumovirus, with two known genotypes named A and B, is associated with mild respiratory symptoms to severe LRTI in children, high-risk adults and the elderly. Rapid and reliable methods of hMPV detection in clinical samples are essential to implement appropriate care, to better understand the pathology of hMPV and to determine its epidemiology. Respiratory samples from 1,386 patients collected during 2 consecutive years were screened for hMPV using indirect immunofluorescence (IFA) assay with a monoclonal antibody. Forty-three patients tested positive for hMPV by the IFA method. In parallel, the samples were examined with RT-PCR on the F gene. Of these, 41 specimens were RT-PCR p…

virusesMESH : AgedMESH : Respiratory Tract InfectionsMESH : Fluorescent Antibody Technique IndirectFusion geneMiceMESH : ChildGenotypeMetapneumovirusRespiratory systemChildFluorescent Antibody Technique IndirectAntigens ViralRespiratory Tract InfectionsCells CulturedComputingMilieux_MISCELLANEOUS[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMice Inbred BALB CParamyxoviridae Infectionsmedicine.diagnostic_testbiologyAntibodies Monoclonalvirus diseasesMESH : AdultInfectious DiseasesMESH : Antibodies MonoclonalMESH : Sensitivity and SpecificityAdultmedicine.drug_classMonoclonal antibodyImmunofluorescenceSensitivity and Specificity[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyVirusHuman metapneumovirusVirologyMESH : MiceMESH : Cells CulturedmedicineAnimalsHumansMESH : Mice Inbred BALB CAgedMESH : HumansMESH : Antigens ViralMESH : Paramyxoviridae Infectionsbiology.organism_classificationVirologyrespiratory tract diseasesMESH : MetapneumovirusMetapneumovirusMESH : Animals
researchProduct

Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of …

2006

Morbidity and mortality in patients with malignancies are increased by viral infections. These mostly are reactivations of asymptomatic latent infections. They primarily concern clinical entities associated with the reactivation of herpes viruses, such as varicella zoster virus (VZV) and cytomegalovirus (CMV). Respiratory tract infections caused by influenza, parainfluenza or respiratory syncytial virus (RSV) are less common. Since reactivation of latent infections has major clinical impact, antiviral prophylaxis is an attractive approach for patients expecting immunosuppression. The main risk factor for clinically relevant reactivation is profound disruption of cellular immune response. Du…

virusesmedicine.medical_treatmentCongenital cytomegalovirus infectionAntineoplastic AgentsNeutropeniamedicine.disease_causeAntiviral AgentsVirusHerpesviridae03 medical and health sciences0302 clinical medicineNeoplasmsmedicineHumansRespiratory tract infectionsbusiness.industryVaricella zoster virusvirus diseasesImmunosuppressionHematologymedicine.disease3. Good healthOncologyVirus Diseases030220 oncology & carcinogenesisImmunologyAlemtuzumabbusinessImmunosuppressive Agents030215 immunologymedicine.drugStem Cell TransplantationAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct